We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
McKesson Corporation | NYSE:MCK | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.83 | -0.16% | 530.27 | 533.80 | 524.89 | 529.65 | 823,336 | 01:00:00 |
By Micah Maidenberg
McKesson Corp. said Wednesday it has revamped its business units, a move the company said will help it operate more efficiently
The distributor of pharmaceuticals and other health products will start using four reportable segments:
U.S. Pharmaceutical and Specialty Solutions segment will focus on wholesale drug distribution and technology products for retail pharmacies, health systems and other clients, the company said, as well as U.S. oncology offerings.
Prescription Technology Solutions encompasses the company's work with biopharma and life sciences partners and patients.
International covers McKesson Canada's and McKesson Europe's drug distribution services, specialty pharmacy, retail and infusion care services in those markets.
The fourth segment, Medical-Surgical Solutions, is unaffected by the realignment, the company said.
"McKesson expects to transition to financial reporting under the new four-segment structure for periods commencing after the first quarter of fiscal 2021," the company added.
Write to Micah Maidenberg at micah.maidenberg@wsj.com
(END) Dow Jones Newswires
July 01, 2020 16:42 ET (20:42 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year McKesson Chart |
1 Month McKesson Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions